| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138287 3-substituted-2(arylalkyl)-1- azabicycloalkanes and methods of use thereof |
| 06/12/2008 | US20080138283 1,2,4-triazole- 3,5-dione derivatives; for imaging and therapy of psychiatric, eating, sleeping, bipolar disorder; anxiolytic agent, antidepressant; Alzheimer's, Parkinson's diseases, epilepsy; imaging agents for a serotonin receptor |
| 06/12/2008 | US20080138282 Radiolabeled Arylsulfonyl Compounds and Uses Thereof |
| 06/12/2008 | US20080138281 with C11 or F18 radioisotops; e.g. O-[18F]Fluoromethyl-L-tyrosine or O-[11C]methyl-L-tyrosine; comparison of the radiation dose of each tissue |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/12/2008 | US20080138279 Method of imaging cell death in vivo |
| 06/12/2008 | US20080138278 Conjugates of rgd peptides and porphyrin or (bacterio) chlorohyll photosynthesizers and their uses |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | US20080138276 Monoclonal antibody produced by hybridoma with IDAC accession number 180706-02; competitive binding of monoclonal antibody, humanized-, chimeric- or cancerous disease modifying antibodies (CDMAB) with tissue sample induces cytotoxicity; anticarcinogenic, antitumor, and antimetastasis agents; diagnosis |
| 06/12/2008 | CA2670061A1 Methods of imaging employing chelating agents |
| 06/12/2008 | CA2667684A1 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 06/11/2008 | EP1928513A2 Cell delivery fluid for prevention of cellsettling in delivery system |
| 06/11/2008 | EP1928508A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 06/11/2008 | EP1928506A2 Dual variable domain immunoglobin and uses thereof |
| 06/11/2008 | EP1928313A1 Self-assembled biodegradable polymersomes |
| 06/11/2008 | EP1197227B9 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 06/11/2008 | CN101198360A A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate |
| 06/11/2008 | CN101198359A Radioactive diagnostic imaging agent |
| 06/11/2008 | CN101194856A Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor |
| 06/11/2008 | CN101194855A Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor |
| 06/10/2008 | US7385054 For use as contrast media; x-ray diagnosis and magnetic resonance imaging |
| 06/10/2008 | US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 06/10/2008 | US7385041 Dual functioning excipient for metal chelate contrast agents |
| 06/10/2008 | US7385025 Comprising biologically active alpha-melanocyte stimulating hormone, gamma-melanocyte stimulating hormone, or bombesin sequence wherein residue comprising nitrogen atom and sulfur atom each available for complexation to metal ion is inserted between two and three position to c-terminus side of n position |
| 06/10/2008 | US7384977 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/10/2008 | US7384910 Peptide consisting of Leu-Ala-Phe-Val-Leu-Arg-Lys-amide having at least one D amino acid |
| 06/10/2008 | US7384753 Growth differentiation factor-11 |
| 06/05/2008 | WO2008064432A1 Polycyclic molecular compounds |
| 06/05/2008 | WO2008046493A3 Radioactive metal complexes comprising a tridentate complexing sequence |
| 06/05/2008 | WO2007075565A3 Diagnostic system for the detection and diagnosis of skin cancer |
| 06/05/2008 | WO2007035405A3 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 06/05/2008 | US20080132992 Coated implantable medical device |
| 06/05/2008 | US20080131369 Compositions And Methods For Enhancing Contrast In Imaging |
| 06/05/2008 | US20080131368 Technetium-base radiopharmaceuticals; biocompatability; kits |
| 06/05/2008 | US20080131367 Composition For Diagnosing Amyloid-Related Diseases |
| 06/05/2008 | US20080131366 Administering folate receptor alpha inducer comprising steroid receptor agent optionally with one or more histone deacetylase inhibitors to treat or diagnose a patient having a solid tumor; increases levels of receptors on cancer cell plasma membranes and in serum, ascites and cerebrospinal fluid |
| 06/05/2008 | US20080131363 Rs7 antibodies |
| 06/05/2008 | US20080131362 Portable labeled radiopharmaceutical agent container; a portable information-bearing joining element, a patient management system, a portable patient-specific data carrier, an automated administration system; computers; imaging |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1926729A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 06/04/2008 | EP1926500A2 Methods of making radiolabeled tracers and precursors thereof |
| 06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381407 Detecting binding to epitope; use in immunoassays, imaging, diagnosis and treatment of cancer |
| 06/03/2008 | US7381399 For use as radiopharmaceuticals; solid phase synthesis; G-protein-coupled receptors |
| 06/03/2008 | CA2435320C Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 05/29/2008 | WO2008064040A2 Methods and compositions using chelator-antibody conjugates |
| 05/29/2008 | WO2008063749A2 Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 05/29/2008 | WO2007138291A3 Novel imaging agents |
| 05/29/2008 | WO2007034210A8 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 05/29/2008 | US20080124274 Compositions and methods for detecting and treating tumors containing acidic areas |
| 05/29/2008 | US20080124273 Novel cationic metal complex radiopharmaceuticals |
| 05/29/2008 | US20080124272 antibodies against influenza neuraminidase antigens; monoclonal antibody or antigen binding fragment |
| 05/29/2008 | US20080124271 Method for preventing nasolacrimal duct obstruction |
| 05/29/2008 | US20080124270 Compounds Useful as Metal Chelators |
| 05/29/2008 | CA2665494A1 Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 05/28/2008 | CN101189339A Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100389825C Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 05/27/2008 | US7378234 Method for isolating hepatitis C virus peptides |
| 05/27/2008 | US7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| 05/27/2008 | US7378079 Agents for imaging and diagnostic methods using them |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/22/2008 | WO2008061020A2 Methods of treating, diagnosing or detecting cancer |
| 05/22/2008 | WO2008060845A2 Radiolabeled vitamin b12 and its derivatives useful for positron emission tomography imaging |
| 05/22/2008 | WO2008060393A2 The use of materials and external stimuli for synovectomy |
| 05/22/2008 | WO2008060368A2 Transglutaminase-binding peptides and methods of use |
| 05/22/2008 | WO2008060367A2 Human antibodies that bind cxcr4 and uses thereof |
| 05/22/2008 | WO2008059714A1 Novel compounds with affinity for amyloid |
| 05/22/2008 | WO2008059489A2 Radioimaging applications of and novel formulations of teboroxime |
| 05/22/2008 | WO2008058381A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008026051A3 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature |
| 05/22/2008 | US20080119699 Method for detecting at least one substance in a metabolic process of a living being and device for carrying out the method |
| 05/22/2008 | US20080119475 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 05/22/2008 | US20080118435 Composition comprising low density microspheres |
| 05/22/2008 | US20080118433 Preparation and method utilizing radiolabeled chlorotoxin |
| 05/22/2008 | US20080118432 Predetermined reference range indicates cancer therapy effectiveness; immunoassay; cancer stem cells bound with labeled antibodies specific for cell surface markers prior to detection in flow cytometer; blood, bone marrow, serum, urine, interstitial fluid; breast, brain cancer, acute lymphoid leukemia |
| 05/22/2008 | CA2669522A1 Novel compounds with affinity for amyloid |
| 05/22/2008 | CA2668503A1 Cancerous disease modifying antibodies 180706-01 |
| 05/22/2008 | CA2668496A1 Cancerous disease modifying antibodies |
| 05/22/2008 | CA2668484A1 Cancerous disease modifying antibodies 180706-02 |
| 05/21/2008 | EP1923382A1 [18F] labelled L-glutamic acid, [18F] labelled glutamine, their derivatives, their use and processes for their preparation |
| 05/21/2008 | EP1482981B1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1157004B1 Composition comprising MX-DTPA and its use to produce a radiolabeled MX-DTPA |
| 05/21/2008 | EP1064005B1 Urokinase plasminogen activator receptor as a target for diagnosis of micrometastases |
| 05/21/2008 | EP0831938B1 Radiolabeled peptide compositions for site-specific targeting |
| 05/21/2008 | CN101182349A Recombinant octreotide and uses thereof |
| 05/21/2008 | CN101182333A 99mTc marked 2-methoxyphenyl piperazine derivative complexes as well as preparation method and uses thereof |
| 05/20/2008 | US7374936 Generation of therapeutic radioconjugate; load isotope onto binding support, elute long lived isotopes, join isotope to targeting particle, recover radioconjugate |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/15/2008 | WO2008056481A1 Radioactive diagnostic imaging agent |
| 05/15/2008 | WO2007139989A3 Tissue sample preparation, and maldi ms imaging thereof |
| 05/15/2008 | WO2007106544A3 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 05/15/2008 | WO2007073479A3 Radiotherapeutic high specific activity tin-117m and methods of use |
| 05/15/2008 | US20080112884 Administering to a patient a contrast agent (pyridimifen, fenazaquin) which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging |